Treatment of Barretts esophagus with high-grade dysplasia or cancer: predictors of surgical versus endoscopic therapy

摘要

IntroductionPatients with Barrett’s esophagus (BE) and high-grade dysplasia (HGD) or intramucosal carcinoma (IMC) are at risk of progression to invasive carcinoma. Both esophagectomy and endoscopic ablation are treatment options. The aim of this study was to identify predictors of surgical versus endoscopic therapy at a tertiary center.